Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/6091
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2022-03-29T17:56:52Z-
dc.date.available2022-03-29T17:56:52Z-
dc.date.issued2020-05-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/6091-
dc.language.isootherpt_BR
dc.publisherINCApt_BR
dc.subjectProtocolos Clínicospt_BR
dc.subjectClinical Protocolspt_BR
dc.subjectTabagismopt_BR
dc.subjectTobacco Use Disorderpt_BR
dc.subjectTabaquismopt_BR
dc.subjectProtocolo de Ensayo Clínico-
dc.titleMS aprova novo Protocolo Clínico e Diretrizes Terapêuticas do Tabagismopt_BR
dc.title.alternativeInforme INCA 395pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 395

Files in This Item:
File Description SizeFormat 
Informe-INCA-2020-395-10-MS-aprova-novo.pdf157.2 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.